Evidence map›Paper›PMID 32145062›Full record

ArticleImmunology2020

NF-κB-inducing kinase contributes to normal development of cortical thymic epithelial cells: its possible role in shaping a proper T-cell repertoire.

Koji Eshima, Kana Misawa, Chihiro Ohashi, Haruka Noma, Kazuya Iwabuchi

Open access · bronzeAbstract read
In one paragraph

Article in Immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Koji EshimaDepartment of Immunology, Kitasato University School of Medicine, Kanagawa, Japan.ORCID 0000-0002-4074-910X
Kana MisawaDepartment of Immunology, Kitasato University School of Medicine, Kanagawa, Japan.
Chihiro OhashiDepartment of Immunology, Kitasato University School of Medicine, Kanagawa, Japan.
Haruka NomaDepartment of Immunology, Kitasato University School of Medicine, Kanagawa, Japan.
Kazuya IwabuchiDepartment of Immunology, Kitasato University School of Medicine, Kanagawa, Japan.
Kitasato University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nuclear factor (NF)-κB-inducing kinase (NIK) is known to be a critical regulator of multiple aspects of the immune response. Although the role of NIK in the development of medullary thymic epithelial cells (mTECs) has been well documented, the impact of NIK on the differentiation and function of cortical thymic epithelial cells (cTECs) remains ambiguous. To investigate the possible involvement of NIK in cTEC differentiation, we have compared the gene expression and function of cTECs from a NIK-mutant mouse, alymphoplasia (aly/aly) with those of cTECs from wild-type (WT) mice. Flow cytometric analyses revealed that expression levels of MHC class II, but not MHC class I or other TEC markers, were higher in aly/aly cells than in WT cells. Notably, the proportion of MHC class II

Indexed as

AnimalsBone Marrow TransplantationCell DifferentiationClonal Selection, Antigen-MediatedEpithelial CellsFemaleFlow CytometryGene Expression ProfilingHistocompatibility Antigens Class IHistocompatibility Antigens Class IIMaleMiceMice, TransgenicMutationNF-kappaB-Inducing KinaseProtein Serine-Threonine KinasesHistocompatibility Antigens Class IHistocompatibility Antigens Class IINF-kappaB-Inducing KinaseProtein Serine-Threonine Kinasescortical thymic epithelial cellsNF-κB-inducing kinaseT-cell repertoirethymic positive selection

Identifiers

PMID32145062
PMCPMC7218659
OpenAlexW3009517941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.